Cardiac Science’s Quinton Merger Bolsters Balance Sheet, Competitiveness
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science's merger with Quinton Cardiology Systems will eliminate debt to facilitate competition in the public-access defibrillator market, the firm says
You may also be interested in...
Cardiac Science Banks On Hospital AED To Reinvigorate Growth In 2006
Cardiac Science is counting on the launch of its "crash-cart" automated external defibrillator to reignite sales after failing to meet internal revenue expectations in 2005
Cardiac Science Banks On Hospital AED To Reinvigorate Growth In 2006
Cardiac Science is counting on the launch of its "crash-cart" automated external defibrillator to reignite sales after failing to meet internal revenue expectations in 2005
RTI’s Silver Lining: Sterling Bone Void Approval Sends Stock Up 21% In August
Regeneration Technologies' receipt of FDA clearance for the Sterling xenograft bone void fillers helped push the firm's stock price up 21% to $9.25 in August